01—Abstract
Summary
Summary of the 8-K filed February 14, 2025. Cited figures are marked; the original filing is the authoritative source.
On February 14, 2025, PPL Corporation entered into an Equity Distribution Agreement under which it may sell, from time to time, up to an aggregate sales price of $2.0 billiona of its common stock, par value $0.01 per share.
Sales may be made through ten named Sales Agents acting as sales agents and/or principals, or through forward sale agreements with Forward Purchasers. Sales would be made under the company's Form S-3 registration statement (File No. 333-277140) filed February 16, 2024, or a subsequent replacement registration statement, and actual sales will depend on market conditions, the trading price of the common stock, capital needs and the company's determination of appropriate funding sources. The filing describes the forward sale structure in detail.
The company will not initially receive proceeds from borrowed shares sold by a Forward Seller, and expects to receive proceeds upon future physical settlement of each Forward Agreement, which are expected on or before the forward maturity date. Forward Sellers receive commissions at a mutually agreed rate not to exceed 2.0%b of the gross sales price of borrowed shares sold. The initial forward sale price is subject to a floating interest rate factor, a reduction for expected quarterly dividends during the forward term, and the company may elect cash or net share settlement, subject to Forward Purchaser acceleration rights.
The company intends to use net proceeds for general corporate purposes. The filing is largely a framework for future equity issuance rather than a completed transaction; it reports no shares sold or proceeds received as of the filing date. Investors should note the potential for future dilution and the forward-sale mechanics, which defer proceeds until settlement.
The filing also includes an opinion and consent of W. Eric Marr, Esq. and the Equity Distribution Agreement as Exhibit 1.1.
02—Key points
Key Highlights
- Equity Distribution Agreement dated February 14, 2025 authorizes sales of up to an aggregate $2.0 billion of PPL common stock
- Sales may occur through ten Sales Agents as agents and/or principals, or via forward sale agreements with Forward Purchasers
- Shares are offered under Form S-3 (File No. 333-277140) filed February 16, 2024, or a subsequent replacement registration statement
- Forward structure means the company initially receives no proceeds from borrowed shares sold; proceeds come upon future physical settlement
- Forward Sellers' commissions are capped at 2.0% of the gross sales price of borrowed shares sold
- Initial forward sale price is adjusted by a floating interest rate factor and reduced by expected quarterly dividends during the forward term
- Net proceeds are intended for general corporate purposes
03—Questions
Frequently Asked Questions
How much equity can PPL sell under this agreement?
PPL may sell, from time to time, up to an aggregate sales price of $2.0 billion of its common stock through or to the Sales Agents, or pursuant to any Forward Agreement.
When will PPL receive cash proceeds from forward sales?
The company will not initially receive proceeds from the sale of borrowed shares by a Forward Seller. It expects to receive proceeds upon future physical settlement of the relevant Forward Agreement, on dates specified in that agreement, which are expected to be on or prior to its maturity date.
What fees do the Forward Sellers receive?
Forward Sellers receive commissions, in the form of a reduced initial forward sale price, at a mutually agreed rate not to exceed 2.0% of the gross sales price of all borrowed shares sold during the applicable forward hedge selling period.
How will PPL use the proceeds?
The company intends to use the net proceeds, after deducting Sales Agents' commissions and offering expenses, and amounts payable upon settlement of any Forward Agreement, for general corporate purposes.
Under what registration statement are the shares being sold?
Shares are offered and sold under the company's Form S-3 registration statement (File No. 333-277140) filed with the SEC on February 16, 2024, or a subsequent replacement registration statement.
04—Continue